A new trading day began on Monday, with ProKidney Corp (NASDAQ: PROK) stock price down -4.04% from the previous day of trading, before settling in for the closing price of $2.23. PROK’s price has ranged from $0.46 to $7.13 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 8.60%. With a float of $105.52 million, this company’s outstanding shares have now reached $135.98 million.
ProKidney Corp (PROK) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ProKidney Corp is 25.45%, while institutional ownership is 28.50%. The most recent insider transaction that took place on Nov 13 ’25, was worth 1,190,062. In this transaction Director of this company sold 502,136 shares at a rate of $2.37, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director sold 255,026 for $2.72, making the entire transaction worth $694,515. This insider now owns 54,333 shares in total.
ProKidney Corp (PROK) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.17 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Here are ProKidney Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 869.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
Compared to the last year’s volume of 1.67 million, its volume of 1.34 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 14.76%.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 6.94%, which indicates a significant decrease from 15.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was lower than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.48, while its 200-day Moving Average is $1.99. Nevertheless, the first resistance level for the watch stands at $2.21 in the near term. At $2.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.34. If the price goes on to break the first support level at $2.08, it is likely to go to the next support level at $2.03. Now, if the price goes above the second support level, the third support stands at $1.95.
ProKidney Corp (NASDAQ: PROK) Key Stats
With a market capitalization of 643.79 million, the company has a total of 300,834K Shares Outstanding. Currently, annual sales are 80 K while annual income is -61,190 K. The company’s previous quarter sales were 220 K while its latest quarter income was -16,470 K.
